At the time of writing, eHealth Inc [EHTH] stock is trading at $5.56, up 10.76%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The EHTH shares have gain 10.54% over the last week, with a monthly amount glided 22.20%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
eHealth Inc [NASDAQ: EHTH] stock has seen the most recent analyst activity on January 18, 2024, when Craig Hallum downgraded its rating to a Hold but kept the price target unchanged to $7 for it. Previously, Craig Hallum upgraded its rating to Buy on December 01, 2022, and kept the price target unchanged to $6. Citigroup downgraded its rating to a Neutral and decreased its price target to $15 on March 21, 2022. Truist downgraded its rating to a Hold. Evercore ISI downgraded its rating to In-line for this stock on March 02, 2022. In a note dated January 18, 2022, Barclays downgraded an Equal Weight rating on this stock but restated the target price of $22.
For the past year, the stock price of eHealth Inc fluctuated between $3.58 and $9.45. Currently, Wall Street analysts expect the stock to reach $7.33 within the next 12 months. eHealth Inc [NASDAQ: EHTH] shares were valued at $5.56 at the most recent close of the market. An investor can expect a potential return of 31.83% based on the average EHTH price forecast.
Analyzing the EHTH fundamentals
According to eHealth Inc [NASDAQ:EHTH], the company’s sales were 464.89M for trailing twelve months, which represents an -9.75% plunge. Gross Profit Margin for this corporation currently stands at 0.99% with Operating Profit Margin at -0.06%, Pretax Profit Margin comes in at -0.07%, and Net Profit Margin reading is -0.17%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.1 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.19 points at the first support level, and at 4.81 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.77, and for the 2nd resistance point, it is at 5.97.
Ratios To Look Out For
Considering the valuation of this stock, the price to sales ratio is 0.35, the price to book ratio is 0.33.
Transactions by insiders
Recent insider trading involved Galimi Gavin G., SVP, General Counsel & Secr., that happened on Aug 20 ’24 when 7000.0 shares were purchased. SVP, General Counsel & Secr., Galimi Gavin G. completed a deal on Aug 08 ’24 to buy 10365.0 shares. Meanwhile, SVP, Chief Financial Officer Stelben John J bought 20000.0 shares on Aug 08 ’24.
